Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

145.68
-3.1800-2.14%
Post-market: 144.81-0.8700-0.60%19:46 EDT
Volume:3.95M
Turnover:576.00M
Market Cap:180.74B
PE:-55.71
High:149.47
Open:149.47
Low:144.88
Close:148.86
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.75
T/O Rate:0.32%
Dividend:3.22
Dividend Rate:2.21%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.28
PE(LYR):21.49

Loading ...

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Reuters
·
Aug 14

Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.

Dow Jones
·
Aug 13

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Dow Jones
·
Aug 13

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Reuters
·
Aug 12

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 12

MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis

Reuters
·
Aug 12

MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development

THOMSON REUTERS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Lakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook

TIPRANKS
·
Aug 11

Lakefront Biotherapeutics H1 FY26 Net Sales Drop 87% to EUR 18.6 Million; Operating Loss Narrows 54% to EUR 107.2 Million

Reuters
·
Aug 11

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Erasca Appoints Charles Fuchs as President of R&D

Reuters
·
Aug 10

Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target

TIPRANKS
·
Aug 08

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Dow Jones
·
Aug 08

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

Gilead Sciences (GILD) Stock Price Reflects R And D Shock Not Sales Weakness

Simply Wall St.
·
Aug 06

Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment

Reuters
·
Aug 06